Supportive Government Policies, Amid the Covid-19 Pandemic, to Promote the Development of Global Assisted Reproductive Technology MarketDownload Sample Reports Overview
The COVID-19 outbreak has created a positive impact on the global assisted reproductive technology market. The growth of the global assisted reproductive technology market is mainly attributed to the rising prevalence of childlessness and infertility disorders and the adoption of novel technological innovations. Owing to the COVID-19 emergency, the majority of the notable players are focussing on various strategies such as product innovations, strategic tie-ups, and the adoption of new technologies. For example, in April 2019, Nova IVF Fertility, leading service provider in infertility space, has adopted ART technologies such as DNA Fragmentation Index (DFI) testing and Magnetic Activated Cell Sorting (MACS) techniques which are providing great benefits to the men with fertility issues in India. In addition to this, in February 2020, the Indian government has made an announcement to approve ‘assisted reproductive technology (ART) regulation bill’, during the outbreak of COVID-19. These key factors may offer lucrative opportunities for the global assisted reproductive technology market growth, throughout the forecast timeframe. By implementing such strategic steps, the global assisted reproductive technology players preparing for the post-outbreak impact.
During the chaotic COVID-19 situation, we are helping our clients in understanding the impact of COVID-19 on global assisted reproductive technology. Our report includes:
- Technological Impact
- Social Impact
- Investment Opportunity Analysis
- Pre- & Post-COVID Market Scenario
- Infrastructure Analysis
- Supply Side & Demand Side Impact
As per the recent publication of Research Dive, the global assisted reproductive technology market is set to register a revenue of $56.3 billion by 2027, at a CAGR of 10.7%, throughout the analysis period. The segmentation of the market has been done based on procedure, technology, end-use, and region. The report provides detailed information on lucrative opportunities, driving factors, vital segments, restraints, and industry players in the global assisted reproductive technology market.
Factors Affecting the Market Growth
As per our analyst estimates, the rising prevalence of infertility diseases owing to the change in lifestyles, smoking, obesity are some of the major factors propelling the global assisted reproductive technology market growth. However, the lack of awareness and lower product penetration in middle and low-income countries are predicted to restrain the growth of the assisted reproductive technology market.
Fresh Nondonor Procedure will be the Rapidly-Growing Procedure, During the Analysis Period
Based on a procedure, the global market for assisted reproductive technology is categorized into a fresh donor, fresh nondonor, frozen donor, frozen nondonor, and embryo/egg banking. The fresh nondonor procedure valued at $17.6 billion and is expected to increase at a CAGR of 11.2% by the end of 2027; owing to the high success rate of fresh nondonor procedure over other procedures.
The IVF Technology Shall have the Exponential Market Share, Throughout the analysis Period
Depending on the technology the global market is mainly divided into IVF technology and others. The IVF technology has a massive market share and is valued at $40.2 billion in 2027 at a CAGR of 11%, throughout the analysis timeframe.
Hospital segment To be the Most Lucrative
Based on end-use, the global assisted reproductive technology market is classified into hospital and fertility clinics. The hospital segment shall have exponential market growth and is expected to register a revenue of $11.2 billion in 2027 at a CAGR of 12.1%, during the analysis timeframe. Enormously rising a rate of hospital admissions coupled with an increasing emphasis on the enhancement of healthcare facilities is predicted to accelerate the segment growth, during the review period.
Geographical Analysis and Major Market Players
Based on the geographical region, the global assisted reproductive technology market is mainly categorized into North America, Europe, Asia Pacific, and LAMEA. The Asia-Pacific assisted reproductive technology market valued at $15.6 billion in 2027 and is projected to increase at a growth rate of 11.6%, during the analysis period. The government support for in-vitro fertilization, the increasing emphasis on the improvement of healthcare infrastructure, and heavy spendings in technological developments mainly in India, South Korea, Australia, and Japan are some of the driving factors of the Asia-Pacific assisted reproductive technology market.
The leading global assisted reproductive technology players consists Merck KGaA, Cook, Nidacon International AB, California Cryobank., IVFtech ApS, FUJIFILM Irvine Scientific., CooperSurgical, Inc., Thermo Fisher Scientific Inc., Hamilton Thorne, Inc., and Ferring Pharmaceuticals.